Transcriptomic profiling across stages of non-muscle-invasive bladder cancer identifies fibroblast activation protein-alpha as a stromal biomarker associated with progression

Murat Akand, J. Alberto Nakauma-González, Tatjana Jatsenko, Thomas Gevaert, Loïc Baekelandt, Marcella Baldewijns, Joris Robert Vermeesch, Frank Van der Aa, Steven Joniau

Open source

DOI
10.1186/s10020-026-01497-2
Published
2026-05-15
Container
Molecular Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s10020-026-01497-2,
  title = {Transcriptomic profiling across stages of non-muscle-invasive bladder cancer identifies fibroblast activation protein-alpha as a stromal biomarker associated with progression},
  author = {Murat Akand and J. Alberto Nakauma-González and Tatjana Jatsenko and Thomas Gevaert and Loïc Baekelandt and Marcella Baldewijns and Joris Robert Vermeesch and Frank Van der Aa and Steven Joniau},
  year = {2026},
  journal = {Molecular Medicine},
  doi = {10.1186/s10020-026-01497-2},
  url = {https://doi.org/10.1186/s10020-026-01497-2}
}

RIS

TY  - JOUR
TI  - Transcriptomic profiling across stages of non-muscle-invasive bladder cancer identifies fibroblast activation protein-alpha as a stromal biomarker associated with progression
AU  - Murat Akand
AU  - J. Alberto Nakauma-González
AU  - Tatjana Jatsenko
AU  - Thomas Gevaert
AU  - Loïc Baekelandt
AU  - Marcella Baldewijns
AU  - Joris Robert Vermeesch
AU  - Frank Van der Aa
AU  - Steven Joniau
PY  - 2026
JO  - Molecular Medicine
DO  - 10.1186/s10020-026-01497-2
UR  - https://doi.org/10.1186/s10020-026-01497-2
ER  - 

APA

Akand, M., Nakauma-González, J. A., Jatsenko, T., Gevaert, T., Baekelandt, L., Baldewijns, M., Vermeesch, J. R., Aa, F. V. D., & Joniau, S. (2026). Transcriptomic profiling across stages of non-muscle-invasive bladder cancer identifies fibroblast activation protein-alpha as a stromal biomarker associated with progression. Molecular Medicine. https://doi.org/10.1186/s10020-026-01497-2

Source records